My husband be diagnosed beside hepatitis C - HELP?
He is in his mid-forties, he acquired the virus 3 or so years back. I want to know what is the outlook (is it terminal?), treatment, risks of treatment, and any other info (personal experience with it?) you can supply me with.
ly appreciate your command.
Answers: Your husband should be fine as long as he gets treatment and can tolerate it. He hasn't had it for very long if it's singular been 3 years so there shouldn't be much damage if any unless he take a lot of other OTC/prescription meds, does recreational drugs, or drinks a lot of alcohol. Most people hold it for decades before finding out and that is usually when a lot of the liver sprain has occured.
The treatment wasn't bad for me like frequent of the horror stories you might run across. I can give you more specifics if you'd like - you can read more on my personal story on the website listed contained by the sources if you want to know more about the virus itself. I have been clear of the virus for over 5 years in a minute...so he can get rid of it if he acts early.
ref="http://www.healhepatitisc.com" rel="nofollow">http://www.healhepatitisc.com
Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but once established, chronic infection can progress to scarring of the liver (fibrosis), and advanced scarring (cirrhosis) which is generally adjectives after many years. In some cases, those with cirrhosis will go on to develop liver damp squib or other complications of cirrhosis, including liver cancer.
The hepatitis C virus (HCV) is spread by blood-to-blood contact. Most people have few, if any symptoms after the initial infection, yet the virus persist in the liver in about 85% of those infected. Persistent infection can be treated beside medication, peginterferon and ribavirin being the standard-of-care therapy. Only 51% are cured overall. Those who develop cirrhosis or liver cancer may require a liver transplant, and the virus universally recurs after transplantation.
Treatment
There is a very small chance of clearing the virus spontaneously surrounded by chronic HCV carriers (0.5 to 0.74% per year), however, the majority of patients with chronic hepatitis C will not clear it without treatment.
ent treatment is a combination of pegylated interferon alpha (brand name Pegasys and PEG-Intron) and the antiviral drug ribavirin for a period of 24 or 48 weeks, depending on genotype. Indications for treatment include patients with proven hepatitis C virus infection and persistent impressive liver function tests. Sustained cure rates (sustained viral response) of 75% or better occur in folks with genotypes HCV 2 and 3 in 24 weeks of treatment, about 50% contained by those with genotype 1 with 48 weeks of treatment and 65% for those with genotype 4 surrounded by 48 weeks of treatment. About 80% of hepatitis C patients in the United States have genotype 1. Genotype 4 is more common surrounded by the Middle East and Africa. Should treatment with pegylated interferon + ribavirin not return a 2-log viral reduction or complete clearance of RNA (termed early virological response) after 12 weeks for genotype 1, the adjectives of treatment success is less than 1%. Early virological response is typically not tested for in non-genotype 1 patients, as the probability of attaining it are greater than 90%. The mechanism of action is not entirely clear, because even patients who appear to have have a sustained virological response still have actively replicating virus in their liver and peripheral blood mononuclear cell.
The evidence for treatment in genotype 6 disease is currently sparse, and the evidence that exists is for 48 weeks of treatment at the same doses as are used for genotype 1 disease. Physicians considering shorter durations of treatment (e.g., 24 weeks) should do so within the context of a clinical trial.
Those next to low initial viral loads respond much better to treatment than those with higher viral loads (greater than 400,000 IU/mL). Current combination therapy is usually supervised by physicians contained by the fields of gastroenterology, hepatology or infectious disease.
The treatment may be physically demanding, particularly for those with a prior history of drug or alcohol maltreat. It can qualify for temporary disability in some cases. A substantial proportion of patients will experience a panoply of side effects ranging from a 'flu-like' syndrome (the most adjectives, experienced for a few days after the weekly injection of interferon) to severe adverse events including anemia, cardiovascular events and psychiatric problems such as suicide or suicidal ideation. The latter are exacerbated by the general physiological stress experienced by the patient.
ent guidelines strongly recommend that hepatitis C patients be vaccinated for hepatitis A and B if they enjoy not yet been exposed to these viruses, as infection beside a second virus could worsen their liver disease.
Alcoholic beverage consumption accelerates HCV associated fibrosis and cirrhosis, and makes liver cancer more likely; insulin resistance and metabolic syndrome may similarly worsen the hepatic prognosis. There is also evidence that smoking increases the fibrosis (scarring) rate.
Several alternative therapies aim to maintain Source(s): http://en.wikipedia.org/wiki/Hepatitis_C
Related Questions:
ly appreciate your command.
Answers: Your husband should be fine as long as he gets treatment and can tolerate it. He hasn't had it for very long if it's singular been 3 years so there shouldn't be much damage if any unless he take a lot of other OTC/prescription meds, does recreational drugs, or drinks a lot of alcohol. Most people hold it for decades before finding out and that is usually when a lot of the liver sprain has occured.
The treatment wasn't bad for me like frequent of the horror stories you might run across. I can give you more specifics if you'd like - you can read more on my personal story on the website listed contained by the sources if you want to know more about the virus itself. I have been clear of the virus for over 5 years in a minute...so he can get rid of it if he acts early.
ref="http://www.healhepatitisc.com" rel="nofollow">http://www.healhepatitisc.com
Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but once established, chronic infection can progress to scarring of the liver (fibrosis), and advanced scarring (cirrhosis) which is generally adjectives after many years. In some cases, those with cirrhosis will go on to develop liver damp squib or other complications of cirrhosis, including liver cancer.
The hepatitis C virus (HCV) is spread by blood-to-blood contact. Most people have few, if any symptoms after the initial infection, yet the virus persist in the liver in about 85% of those infected. Persistent infection can be treated beside medication, peginterferon and ribavirin being the standard-of-care therapy. Only 51% are cured overall. Those who develop cirrhosis or liver cancer may require a liver transplant, and the virus universally recurs after transplantation.
Treatment
There is a very small chance of clearing the virus spontaneously surrounded by chronic HCV carriers (0.5 to 0.74% per year), however, the majority of patients with chronic hepatitis C will not clear it without treatment.
ent treatment is a combination of pegylated interferon alpha (brand name Pegasys and PEG-Intron) and the antiviral drug ribavirin for a period of 24 or 48 weeks, depending on genotype. Indications for treatment include patients with proven hepatitis C virus infection and persistent impressive liver function tests. Sustained cure rates (sustained viral response) of 75% or better occur in folks with genotypes HCV 2 and 3 in 24 weeks of treatment, about 50% contained by those with genotype 1 with 48 weeks of treatment and 65% for those with genotype 4 surrounded by 48 weeks of treatment. About 80% of hepatitis C patients in the United States have genotype 1. Genotype 4 is more common surrounded by the Middle East and Africa. Should treatment with pegylated interferon + ribavirin not return a 2-log viral reduction or complete clearance of RNA (termed early virological response) after 12 weeks for genotype 1, the adjectives of treatment success is less than 1%. Early virological response is typically not tested for in non-genotype 1 patients, as the probability of attaining it are greater than 90%. The mechanism of action is not entirely clear, because even patients who appear to have have a sustained virological response still have actively replicating virus in their liver and peripheral blood mononuclear cell.
The evidence for treatment in genotype 6 disease is currently sparse, and the evidence that exists is for 48 weeks of treatment at the same doses as are used for genotype 1 disease. Physicians considering shorter durations of treatment (e.g., 24 weeks) should do so within the context of a clinical trial.
Those next to low initial viral loads respond much better to treatment than those with higher viral loads (greater than 400,000 IU/mL). Current combination therapy is usually supervised by physicians contained by the fields of gastroenterology, hepatology or infectious disease.
The treatment may be physically demanding, particularly for those with a prior history of drug or alcohol maltreat. It can qualify for temporary disability in some cases. A substantial proportion of patients will experience a panoply of side effects ranging from a 'flu-like' syndrome (the most adjectives, experienced for a few days after the weekly injection of interferon) to severe adverse events including anemia, cardiovascular events and psychiatric problems such as suicide or suicidal ideation. The latter are exacerbated by the general physiological stress experienced by the patient.
ent guidelines strongly recommend that hepatitis C patients be vaccinated for hepatitis A and B if they enjoy not yet been exposed to these viruses, as infection beside a second virus could worsen their liver disease.
Alcoholic beverage consumption accelerates HCV associated fibrosis and cirrhosis, and makes liver cancer more likely; insulin resistance and metabolic syndrome may similarly worsen the hepatic prognosis. There is also evidence that smoking increases the fibrosis (scarring) rate.
Several alternative therapies aim to maintain Source(s): http://en.wikipedia.org/wiki/Hepatitis_C
Related Questions:
- Sharp anguish within butt nouns and horrible stomach tenderness?
- Do i own mono?? drank from friends dampen bottle?
- Schizophrenia? What is this?
- What is wrong beside me? (vision loss/headaches)?
- I hold gout... i enjoy to hold clear of foods rich surrounded by iron... Is folic bitter bleak too?
- Mirizzi's syndrome ensue due to compression of adjectives hepatic duct or adjectives bile duct........?